Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-05-10
1978-08-08
Garner, Vivian
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
26032614T, 260404, 2604045, 2605005H, 26050111, 26050112, 260516, 260518R, 260519, 260534C, 260534E, 260534G, 260534L, 424273R, 424274, 424313, 424316, 424318, 424319, 548344, 560 16, 560 34, 560 39, 560 40, 560 41, 560153, 560156, 560168, 560169, 560170, 560171, A61K 31195, A61K 31215, C07C10384
Patent
active
041057899
ABSTRACT:
New carboxyalkylacylamino acids which have the general formula ##STR1## are useful as angiotensin converting enzyme inhibitors.
REFERENCES:
patent: 3462535 (1969-08-01), Loev et al.
patent: 3551419 (1970-12-01), Re et al.
patent: 3852338 (1974-12-01), Kaiser et al.
patent: 3896166 (1975-07-01), Kaiser et al.
Cushman David W.
Ondetti Miguel Angel
E. R. Squibb & Sons Inc.
Garner Vivian
Levinson Lawrence S.
Smith Merle J.
LandOfFree
Carboxyalkylacylamino acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carboxyalkylacylamino acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxyalkylacylamino acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-919704